How Aspirin May Lower Risk for Colorectal Cancer (Medscape)

A new study highlights how aspirin may reduce the risk of colorectal cancer. Researchers found that aspirin’s anti-inflammatory properties and its ability to inhibit cyclooxygenase enzymes play a crucial role in preventing the development of colorectal cancer. By targeting these enzymes, aspirin reduces the production of prostaglandins, which are involved in inflammation and tumor growth. The findings support the potential of aspirin as a preventive measure against colorectal cancer, though further studies are needed to refine dosage and identify at-risk populations.